Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lipid nanoparticle drug delivery tech
Research
Poseida gene therapy reduces kallikrein protein levels in mice
At the minimally effective dose of 0.125 milligrams per kilogram, kallikrein levels were reduced in the mouse model by 58%, the company said.
Darren Incorvaia
Oct 24, 2024 1:20pm
Editas prioritizes in vivo therapies, seeks reni-cel partner
Oct 22, 2024 9:39am
Repair licenses Genevant's tech for up to $107M per product
Sep 26, 2024 2:53pm
Novo inks $600M NanoVation deal to study genetic drugs ex-liver
Sep 18, 2024 9:03am
Ethris' inhaled mRNA asthma drug safely boosts target protein
Jun 28, 2024 7:25am
mRNA vaccine for glioblastoma targets tumors in humans and dogs
May 7, 2024 5:30am
